A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose

Santhosh Karanth, J. D. Adams, Maria de los Angeles Serrano, Ezekiel B. Quittner-Strom, Judith Simcox, Claudio J. Villanueva, Lale Ozcan, William L. Holland, H. Joseph Yost, Adrian Vella, Amnon Schlegel

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The common genetic variation at rs8004664 in the FOXN3 gene is independently and significantly associated with fasting blood glucose, but not insulin, in non-diabetic humans. Recently, we reported that primary hepatocytes from rs8004664 hyperglycemia risk allele carriers have increased FOXN3 transcript and protein levels and liver-limited overexpression of human FOXN3, a transcriptional repressor that had not been implicated in metabolic regulation previously, increases fasting blood glucose in zebrafish. Here, we find that injection of glucagon into mice and adult zebrafish decreases liver Foxn3 protein and transcript levels. Zebrafish foxn3 loss-of-function mutants have decreased fasting blood glucose, blood glucagon, liver gluconeogenic gene expression, and α cell mass. Conversely, liver-limited overexpression of foxn3 increases α cell mass. Supporting these genetic findings in model organisms, non-diabetic rs8004664 risk allele carriers have decreased suppression of glucagon during oral glucose tolerance testing. By reciprocally regulating each other, liver FOXN3 and glucagon control fasting glucose.

Original languageEnglish (US)
Pages (from-to)312-319
Number of pages8
JournalCell Reports
Volume24
Issue number2
DOIs
StatePublished - Jul 10 2018

Fingerprint

Glucagon
Liver
Hepatocytes
Fasting
Glucose
Zebrafish
Blood Glucose
Alleles
Glucose Tolerance Test
Gene expression
Hyperglycemia
Proteins
Blood
Genes
Insulin
Gene Expression
Injections
Testing

Keywords

  • fasting metabolism
  • FOXN3
  • glucagon
  • human
  • mouse
  • type 2 diabetes mellitus
  • zebrafish
  • α cell

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Karanth, S., Adams, J. D., Serrano, M. D. L. A., Quittner-Strom, E. B., Simcox, J., Villanueva, C. J., ... Schlegel, A. (2018). A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose. Cell Reports, 24(2), 312-319. https://doi.org/10.1016/j.celrep.2018.06.039

A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose. / Karanth, Santhosh; Adams, J. D.; Serrano, Maria de los Angeles; Quittner-Strom, Ezekiel B.; Simcox, Judith; Villanueva, Claudio J.; Ozcan, Lale; Holland, William L.; Yost, H. Joseph; Vella, Adrian; Schlegel, Amnon.

In: Cell Reports, Vol. 24, No. 2, 10.07.2018, p. 312-319.

Research output: Contribution to journalArticle

Karanth, S, Adams, JD, Serrano, MDLA, Quittner-Strom, EB, Simcox, J, Villanueva, CJ, Ozcan, L, Holland, WL, Yost, HJ, Vella, A & Schlegel, A 2018, 'A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose', Cell Reports, vol. 24, no. 2, pp. 312-319. https://doi.org/10.1016/j.celrep.2018.06.039
Karanth S, Adams JD, Serrano MDLA, Quittner-Strom EB, Simcox J, Villanueva CJ et al. A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose. Cell Reports. 2018 Jul 10;24(2):312-319. https://doi.org/10.1016/j.celrep.2018.06.039
Karanth, Santhosh ; Adams, J. D. ; Serrano, Maria de los Angeles ; Quittner-Strom, Ezekiel B. ; Simcox, Judith ; Villanueva, Claudio J. ; Ozcan, Lale ; Holland, William L. ; Yost, H. Joseph ; Vella, Adrian ; Schlegel, Amnon. / A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose. In: Cell Reports. 2018 ; Vol. 24, No. 2. pp. 312-319.
@article{274d4084b4384cb48173ff23473dbaa3,
title = "A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose",
abstract = "The common genetic variation at rs8004664 in the FOXN3 gene is independently and significantly associated with fasting blood glucose, but not insulin, in non-diabetic humans. Recently, we reported that primary hepatocytes from rs8004664 hyperglycemia risk allele carriers have increased FOXN3 transcript and protein levels and liver-limited overexpression of human FOXN3, a transcriptional repressor that had not been implicated in metabolic regulation previously, increases fasting blood glucose in zebrafish. Here, we find that injection of glucagon into mice and adult zebrafish decreases liver Foxn3 protein and transcript levels. Zebrafish foxn3 loss-of-function mutants have decreased fasting blood glucose, blood glucagon, liver gluconeogenic gene expression, and α cell mass. Conversely, liver-limited overexpression of foxn3 increases α cell mass. Supporting these genetic findings in model organisms, non-diabetic rs8004664 risk allele carriers have decreased suppression of glucagon during oral glucose tolerance testing. By reciprocally regulating each other, liver FOXN3 and glucagon control fasting glucose.",
keywords = "fasting metabolism, FOXN3, glucagon, human, mouse, type 2 diabetes mellitus, zebrafish, α cell",
author = "Santhosh Karanth and Adams, {J. D.} and Serrano, {Maria de los Angeles} and Quittner-Strom, {Ezekiel B.} and Judith Simcox and Villanueva, {Claudio J.} and Lale Ozcan and Holland, {William L.} and Yost, {H. Joseph} and Adrian Vella and Amnon Schlegel",
year = "2018",
month = "7",
day = "10",
doi = "10.1016/j.celrep.2018.06.039",
language = "English (US)",
volume = "24",
pages = "312--319",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose

AU - Karanth, Santhosh

AU - Adams, J. D.

AU - Serrano, Maria de los Angeles

AU - Quittner-Strom, Ezekiel B.

AU - Simcox, Judith

AU - Villanueva, Claudio J.

AU - Ozcan, Lale

AU - Holland, William L.

AU - Yost, H. Joseph

AU - Vella, Adrian

AU - Schlegel, Amnon

PY - 2018/7/10

Y1 - 2018/7/10

N2 - The common genetic variation at rs8004664 in the FOXN3 gene is independently and significantly associated with fasting blood glucose, but not insulin, in non-diabetic humans. Recently, we reported that primary hepatocytes from rs8004664 hyperglycemia risk allele carriers have increased FOXN3 transcript and protein levels and liver-limited overexpression of human FOXN3, a transcriptional repressor that had not been implicated in metabolic regulation previously, increases fasting blood glucose in zebrafish. Here, we find that injection of glucagon into mice and adult zebrafish decreases liver Foxn3 protein and transcript levels. Zebrafish foxn3 loss-of-function mutants have decreased fasting blood glucose, blood glucagon, liver gluconeogenic gene expression, and α cell mass. Conversely, liver-limited overexpression of foxn3 increases α cell mass. Supporting these genetic findings in model organisms, non-diabetic rs8004664 risk allele carriers have decreased suppression of glucagon during oral glucose tolerance testing. By reciprocally regulating each other, liver FOXN3 and glucagon control fasting glucose.

AB - The common genetic variation at rs8004664 in the FOXN3 gene is independently and significantly associated with fasting blood glucose, but not insulin, in non-diabetic humans. Recently, we reported that primary hepatocytes from rs8004664 hyperglycemia risk allele carriers have increased FOXN3 transcript and protein levels and liver-limited overexpression of human FOXN3, a transcriptional repressor that had not been implicated in metabolic regulation previously, increases fasting blood glucose in zebrafish. Here, we find that injection of glucagon into mice and adult zebrafish decreases liver Foxn3 protein and transcript levels. Zebrafish foxn3 loss-of-function mutants have decreased fasting blood glucose, blood glucagon, liver gluconeogenic gene expression, and α cell mass. Conversely, liver-limited overexpression of foxn3 increases α cell mass. Supporting these genetic findings in model organisms, non-diabetic rs8004664 risk allele carriers have decreased suppression of glucagon during oral glucose tolerance testing. By reciprocally regulating each other, liver FOXN3 and glucagon control fasting glucose.

KW - fasting metabolism

KW - FOXN3

KW - glucagon

KW - human

KW - mouse

KW - type 2 diabetes mellitus

KW - zebrafish

KW - α cell

UR - http://www.scopus.com/inward/record.url?scp=85049314757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049314757&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2018.06.039

DO - 10.1016/j.celrep.2018.06.039

M3 - Article

C2 - 29996093

AN - SCOPUS:85049314757

VL - 24

SP - 312

EP - 319

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 2

ER -